.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Chinese Patent Office
Cerilliant
McKesson
Dow
Moodys
Argus Health
QuintilesIMS
AstraZeneca

Generated: December 18, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: delavirdine mesylate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Viiv HlthcareRESCRIPTORdelavirdine mesylateTABLET;ORAL020705NDAKAISER FOUNDATION HOSPITALS0179-0096-7030 TABLET in 1 BOX, UNIT-DOSE (0179-0096-70)
Viiv HlthcareRESCRIPTORdelavirdine mesylateTABLET;ORAL020705NDAViiV Healthcare Company49702-209-24360 TABLET in 1 BOTTLE (49702-209-24)
Viiv HlthcareRESCRIPTORdelavirdine mesylateTABLET;ORAL020705NDAViiV Healthcare Company49702-225-17180 TABLET in 1 BOTTLE (49702-225-17)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Dow
Covington
Express Scripts
Merck
Fish and Richardson
Chinese Patent Office
Boehringer Ingelheim
Moodys

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot